Skip to main content
OpenTrials

Clinical trial condition

Demyelinating Diseases

Explore clinical trials studying Demyelinating Diseases. Study availability and eligibility vary by location and protocol.

2,934 public trials 459 recruiting studies
Refine in advanced search Browse all conditions

Demyelinating Diseases trial results

Completed

Natalizumab (BG00002, Tysabri) Study in Japanese Participants With Relapsing-Remitting Multiple Sclerosis (RRMS)

NCT01440101

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Research Site Chiba, Japan
  • Research Site Fukuoka, Japan
  • Research Site Hiroshima, Japan
  • Research Site Kawagoe, Japan
View all 17 locations
View Trial Details
Completed

Efficacy and Safety Study of Peginterferon Beta-1a in Participants With Relapsing Multiple Sclerosis

NCT00906399

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +9 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site Ponte Vedra Beach, Florida, United States
  • Research Site Atlanta, Georgia, United States
  • Research Site Des Moines, Iowa, United States
View all 178 locations
View Trial Details
Completed

Persistence, Adherence, Quality of Life, and Treatment Satisfaction With Avonex® PEN™.

NCT01405872

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Research Site Glostrup Municipality, Denmark
  • Research Site Holstebro, Denmark
  • Research Site Næstved, Denmark
  • Research Site Amiens, France
View all 64 locations
View Trial Details
Completed

Safety Study of Natalizumab to Treat Multiple Sclerosis (MS)

NCT00559702

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site Scottsdale, Arizona, United States
  • Research Site Berkeley, California, United States
  • Research Site Centennial, Colorado, United States
View Trial Details

Related conditions